REDCARE PHARMACY : Deutsche Bank keeps its Buy rating
In a research note published by Jan Koch, Deutsche Bank advises its customers to buy the stock. The target price is unchanged at EUR 178.
Source: marketscreener.com
Jan Koch News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Jan Koch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Jan Koch Today - Breaking & Trending Today
ONWARD® Medical Convocation of the 2024 Annual General Meeting of Shareholders and Proposed Resolutions
EINDHOVEN, the Netherlands, May 02, 2024 -- ONWARD Medical N.V. , a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence...
Source: marketscreener.com
STRATEC BIOMEDICAL SYSTEMS AG : Deutsche Bank reiterates its Neutral rating
In a research note published by Jan Koch, Deutsche Bank gives a Neutral rating to the stock. The target price is unchanged at EUR 40.
Source: marketscreener.com
REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating
Deutsche Bank analyst Jan Koch maintains his Buy rating on the stock. The target price is still set at EUR 178.
Source: marketscreener.com
DOCMORRIS : Deutsche Bank remains its Buy rating
In a research note, Deutsche Bank analyst Jan Koch has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at CHF 110.
Source: marketscreener.com